Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2010

View Archived Issues

Achillion selects ACH-2928 as lead candidate against HCV infection

Clinical phase III data presented on linagliptin in type 2 diabetes

IL-7 gene SNPs correlate with rapid HPV clearance in HIV-1-infected subjects

KIF5A, CD226 and SH2B3 gene variants linked to autoimmune diseases

New PET tracer [18F]-MK-3328 for AD diagnosis advances in phase I trial

Genticel's phase I ProCervix trial in HPV-infected women cleared in Belgium

Cytokinetics receives NINDS grant for CK-2017357 development

Tibotec submits NDA for HIV therapeutic TMC-278 to FDA

Onyx presents phase IIb data on carfilzomib in multiple myeloma

FDA grants orphan drug status to BiovaxID for mantle cell lymphoma

Prana Biotechnology claims new quinazolinones for PD

AVEO pays XOMA milestone after starting phase II AV-299 trial

Xenon Pharma discloses new voltage-gated sodium channel blockers

Health Canada clears phase II iCo-007 trial in diabetic macular edema

Canadian scientists discover new agents to deliver antineoplastic therapy

Arena identifies novel prostanoid IP1 receptor agonists

U.S. researchers present new PKR1/PKR2 receptor antagonists

FDA approves Daiichi Sankyo's Tribenzor for hypertension

Titan Pharma receives NIH grant to develop long-term PD therapy

Ampio completes negotiations to acquire DMI BioSciences

QRxPharma to submit MAA for MoxDuo IR analgesic in Germany

CF-102 decreases HCV load in phase I/II trial in liver cancer

FDA posts briefing materials on AstraZeneca's ticagrelor NDA

CHMP issues positive opinion on Arixtra use for superficial vein thrombosis

FIT-06 shows promise in treatment-naive HIV-1-infected subjects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...